United States. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech
United States. Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination
United States. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 Vaccine